Knight Therapeutics Announces Launch of Minjuvi® (tafasitamab) in Mexico
MONTREAL, March 26, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight"), a pan-American (ex-US) specialty pharmaceutical company, announced today the launch of Minjuvi ® ...
Former Tobacco Executive Promotes Anti-Smoking Campaign: A Journey from Habit to Health
In a surprising turn of events, former National Committee member He Zhuguo, once a prominent figure in the tobacco industry, is now collaborating with Hong Kong's Secretary for Food and Health, Dr. LO ...
Former Tobacco Businessman Calls for Smoking Cessation After Lung Cancer Recovery
He Zhuguo has experienced the harsh realities of lung cancer diagnosis and treatment. Transitioning from a successful career in the tobacco industry, he faced chemotherapy that he described as ...
Hyundai ADM Demonstrates Anti-Metastatic Effect of 'PenetriumTM' in TNBC Preclinical Study
Hyundai ADM Bio (KOSDAQ symbol 187660) announced on the 24th that its first-in-class pseudo-resistance-targeting agent, ...
Actuate Therapeutics: Looking To Make An Impact In Pancreatic Cancer
Actuate Therapeutics' elraglusib shows promise for pancreatic cancer, but financial instability and risks make it a high-risk ...
Junshi Biosciences Announces Toripalimab's Approval in Singapore
Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery ...
Leap Therapeutics, Inc.: Leap Therapeutics Reports Positive Updated Data from Sirexatamab Colorectal Cancer Study
Updated data confirms statistically significant 32% higher ORR and 3.5 month longer PFS in second-line CRC patients with high DKK1 levels treated with sirexatamab plus ...